

IN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics


UK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service


MaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO


MaxCyte Annual Loss Widens As Carma Investment Increases


UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost


(Sharecast News) - Life sciences company MaxCyte announced the consolidation of its two lines of common stock into a single unrestricted line of commo...


(Sharecast News) - Clinical-stage life sciences company MaxCyte told investors on Monday that its board was "exceptionally positive" of the group's fu...


MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue